{
    "Trade/Device Name(s)": [
        "BioFire RP2.1/RP2.1plus Control Panel M441"
    ],
    "Submitter Information": "Maine Molecular Quality Controls, Inc.",
    "510(k) Number": "K202196",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173171"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "June 24, 2021",
    "Summary Letter Received Date": "August 5, 2020",
    "Submission Date": "July 30, 2020",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Adenovirus",
        "Coronavirus 229E",
        "Coronavirus HKU1",
        "Coronavirus NL63",
        "Coronavirus OC43",
        "Middle East Respiratory Syndrome Coronavirus",
        "Severe Acute Respiratory Syndrome Coronavirus 2",
        "Human Metapneumovirus",
        "Human Rhinovirus/Enterovirus",
        "Influenza A",
        "Influenza A subtype H1",
        "Influenza A subtype H1-2009",
        "Influenza A subtype H3",
        "Influenza B",
        "Parainfluenza Virus 1",
        "Parainfluenza Virus 2",
        "Parainfluenza Virus 3",
        "Parainfluenza Virus 4",
        "Respiratory Syncytial Virus",
        "Bordetella parapertussis",
        "Bordetella pertussis",
        "Chlamydia pneumoniae",
        "Mycoplasma pneumoniae"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Viral Transport Media (VTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "BioFire FilmArray systems",
        "BioFire FilmArray 2.0",
        "BioFire Torch"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid testing",
        "Reverse transcription",
        "Amplification",
        "Detection",
        "Identification"
    ],
    "Methodologies": [
        "Synthetic RNA transcript assay",
        "Multiplex PCR"
    ],
    "Submission Type(s)": [
        "Control",
        "Panel",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for BioFire RP2.1/RP2.1plus Control Panel M441 as an external quality control for BioFire multiplex respiratory pathogen panels including SARS-CoV-2",
    "Indications for Use Summary": "External positive and negative quality control to monitor performance of in vitro nucleic acid tests for detection of multiple respiratory pathogens on BioFire Respiratory Panel 2.1 assays",
    "fda_folder": "Microbiology"
}